GM01858
Fibroblast from Tumor, Neurofibroma
Description:
NEUROFIBROMATOSIS, TYPE I; NF1
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Hereditary Cancers |
| Class |
Other Disorders of Known Biochemistry |
|
Biopsy Source
|
Neurofibroma
|
|
Cell Type
|
Fibroblast
|
|
Tissue Type
|
Tumor
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
Fibroblast from Tumor, Neurofibroma
|
|
Race
|
White
|
|
Family Member
|
1
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
5 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase and Glucose-6-Phosphate Dehydrogenase Isoenzyme Electrophoresis |
| |
| Remarks |
Neurofibroma (skin) biopsy-fibroblast culture; see GM01861A Lymphoid |
| Combemale P, Sonzogni L, Devic C, Bencokova Z, Ferlazzo ML, Granzotto A, Burlet SF, Pinson S, Amini-Adle M, Al-Choboq J, Bodgi L, Bourguignon M, Balosso J, Bachelet JT, Foray N, Individual Response to Radiation of Individuals with Neurofibromatosis Type I: Role of the ATM Protein and Influence of Statins and Bisphosphonates Molecular neurobiology: 2020 |
| PubMed ID: 34727321 |
| |
| Ling JQ, Hou A, Hoffman AR, Long-range DNA interactions are specifically altered by locked nucleic acid-targeting of a CTCF binding site Biochimica et biophysica acta1809:24-33 2010 |
| PubMed ID: 21111075 |
| Passage Frozen |
5 |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|